Assembly Biosciences (ASMB) Change in Receivables (2017 - 2026)
Assembly Biosciences (ASMB) recorded quarterly Change in Receivables of -$523000.0 in Q1 2026, down 943.55% quarter-over-quarter from $62000.0 in Q4 2025.
Assembly Biosciences (ASMB) Change in Receivables (2017 - 2026) Analysis & Trends
Assembly Biosciences' Change in Receivables history runs 10 years deep, the most recent figure standing at -$523000.0 for Q1 2026.
- In Q1 2026, Change in Receivables changed N/A year-over-year to -$523000.0; the TTM figure through Mar 2026 stood at $451000.0 (up 1148.84% YoY), while the FY2025 annual figure was $974000.0, up 2365.12% from the prior year.
- Change in Receivables was -$523000.0 for Q1 2026 at Assembly Biosciences, down from $62000.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $912000.0 in Q3 2025 to a low of -$523000.0 in Q1 2026.
- Historically, Change in Receivables has averaged $9583.3 across 5 years, with a median of -$22000.0 in 2022.
- The sharpest annual moves came in 2022 and 2023: Change in Receivables soared 118.31% in 2022, then plunged 37400.0% in 2023.
- A 5-year view of Change in Receivables shows it stood at -$302000.0 in 2022, then jumped by 114.24% to $43000.0 in 2023, then tumbled by 200.0% to -$43000.0 in 2024, then surged by 244.19% to $62000.0 in 2025, then sank by 943.55% to -$523000.0 in 2026.
- The last three Change in Receivables figures came in at -$523000.0 (Q1 2026), $62000.0 (Q4 2025), and $912000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -4.08 Mn |
| 10 | Assembly Biosciences | 418.96 Mn | 192.36 Mn | - | -523,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -523,000.00 |
| Mar 31, 2026 | -523,000.00 |
| Dec 31, 2025 | 62,000.00 |
| Dec 31, 2025 | 62,000.00 |
| Sep 30, 2025 | 912,000.00 |
| Sep 30, 2025 | 912,000.00 |
| Jun 30, 2024 | -43,000.00 |
| Jun 30, 2024 | -43,000.00 |
| Dec 31, 2023 | 43,000.00 |
| Dec 31, 2023 | 43,000.00 |
| Sep 30, 2023 | -342,000.00 |
| Sep 30, 2023 | -342,000.00 |
| Jun 30, 2023 | -375,000.00 |
| Jun 30, 2023 | -375,000.00 |
| Mar 31, 2023 | -227,000.00 |
| Mar 31, 2023 | -227,000.00 |
| Dec 31, 2022 | -302,000.00 |
| Dec 31, 2022 | -302,000.00 |
| Sep 30, 2022 | 723,000.00 |
| Sep 30, 2022 | 723,000.00 |